Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wanner

Showing results (31-40 of 206) with videos related to

Pageof 21
Sort By:
Der Internist|April 20, 2021
[Finerenone in patients with chronic kidney disease and type 2 diabetes mellitus]C Wanner, S Nitschmann
Nephron|January 1, 1988
Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspectsC Wanner, W H Hörl
Klinische Wochenschrift|July 1, 1986
Potential role of carnitine in patients with renal insufficiencyC Wanner, W H Hörl
Current Opinion in Urology|April 29, 2000
Impact of dyslipidaemia in renal transplant recipientsC Wanner, T Quaschning, K Weingärnter
Bioseparation|February 1, 1995
In vitro and in vivo studies with different precipitate filter cartridges for H.E.L.P.-LDL-apheresis. Optimization of precipitate filter cartridgesG Morsch, F Maywald, C Wanner
Kidney International. Supplement|July 21, 1999
Atherogenic lipoproteins, oxidative stress, and cell deathJ Galle, K Heermeier, C Wanner
The Journal of Laboratory and Clinical Medicine|November 1, 1995
Effects of insulin-like growth factor I on phosphate transport in cultured proximal tubule cellsR Hirschberg, H Ding, C Wanner
European Heart Journal|November 1, 1993
Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endotheliumJ Galle, P Schollmeyer, C Wanner
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 23, 2008
Lipid lowering in end-stage renal diseaseC Wanner, T Metzger, V Krane
European Journal of Clinical Pharmacology|July 8, 2003
Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysisG Kungys, H Naujoks, C Wanner
Pageof 21

Showing results (31-40 of 206) with videos related to

Sort By:
Pageof 21
Der Internist|April 20, 2021
[Finerenone in patients with chronic kidney disease and type 2 diabetes mellitus]C Wanner, S Nitschmann
Nephron|January 1, 1988
Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspectsC Wanner, W H Hörl
Klinische Wochenschrift|July 1, 1986
Potential role of carnitine in patients with renal insufficiencyC Wanner, W H Hörl
Current Opinion in Urology|April 29, 2000
Impact of dyslipidaemia in renal transplant recipientsC Wanner, T Quaschning, K Weingärnter
Bioseparation|February 1, 1995
In vitro and in vivo studies with different precipitate filter cartridges for H.E.L.P.-LDL-apheresis. Optimization of precipitate filter cartridgesG Morsch, F Maywald, C Wanner
Kidney International. Supplement|July 21, 1999
Atherogenic lipoproteins, oxidative stress, and cell deathJ Galle, K Heermeier, C Wanner
The Journal of Laboratory and Clinical Medicine|November 1, 1995
Effects of insulin-like growth factor I on phosphate transport in cultured proximal tubule cellsR Hirschberg, H Ding, C Wanner
European Heart Journal|November 1, 1993
Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endotheliumJ Galle, P Schollmeyer, C Wanner
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 23, 2008
Lipid lowering in end-stage renal diseaseC Wanner, T Metzger, V Krane
European Journal of Clinical Pharmacology|July 8, 2003
Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysisG Kungys, H Naujoks, C Wanner
Pageof 21